Samenvatting
Samenvatting ziekteleer (Prof. Dierickx) (E0F10A)
- Instelling
- Katholieke Universiteit Leuven (KU Leuven)
Volledige samenvatting ziekteleer van deel Prof Dierickx van schakelstudent seksuologie
[Meer zien]Voorbeeld 6 van de 53 pagina's
Voorbeeld 6 van de 53 pagina's
In winkelwagenVerkoper
Volgen
Voorbeeld van de inhoud
ZIEKTELEER (PROF.DIERICKX)
Academiejaar ’23 – ‘24
0
,INHOUDSOPGAVE
H1: KANKER ................................................................................................................................. 1
ALGEMEEN .......................................................................................................................................... 1
Definitie en kenmerken ................................................................................................................. 1
statistieken .................................................................................................................................. 2
Indeling ........................................................................................................................................ 2
diagnostisch pad .......................................................................................................................... 3
Symptomen.................................................................................................................................. 3
Lokale effecten (primaire tumor of metastasen) .......................................................................................... 3
lonkgkanker ........................................................................................................................................... 3
borstkanker ........................................................................................................................................... 4
Darmkanker ........................................................................................................................................... 4
huidkanker............................................................................................................................................. 4
centraal zenuwstelsel tumoren ............................................................................................................... 4
hematologische tumoren ....................................................................................................................... 5
metastasen ........................................................................................................................................... 5
niet-specifieke symptomen ........................................................................................................................ 5
metabole effecten...................................................................................................................................... 5
Tumor lysis syndroom ............................................................................................................................ 6
paraneoplastische symptomen .................................................................................................................. 6
Myasthenia gravis .................................................................................................................................. 6
alarmsymptomen ...................................................................................................................................... 7
Performantiestatus ....................................................................................................................... 7
Diagnose ...................................................................................................................................... 7
Bloedresultaten ......................................................................................................................................... 7
tumormerkers ........................................................................................................................................ 8
Histologische classificatie.......................................................................................................................... 8
Staging ...................................................................................................................................................... 8
lymfomen .............................................................................................................................................. 9
Solide (vaste) tumoren ........................................................................................................................... 9
Beeldvorming......................................................................................................................................... 9
OORZAKEN ........................................................................................................................................ 10
Medicatie ....................................................................................................................................10
biologische agentia ......................................................................................................................10
beroepsblootstelling/omgevingsfactoren ......................................................................................11
straling ........................................................................................................................................11
voeding .......................................................................................................................................11
middelen.....................................................................................................................................11
PREVENTIE......................................................................................................................................... 12
primaire preventie .......................................................................................................................12
secundaire preventie ...................................................................................................................12
Borstkanker ..............................................................................................................................................12
baarmoederhalskanker .............................................................................................................................13
colorectale kanker ....................................................................................................................................13
longkanker................................................................................................................................................13
prostaatkanker .........................................................................................................................................13
Melanoom ................................................................................................................................................14
BEHANDELING .................................................................................................................................... 14
chemotherapie ............................................................................................................................14
celcyclus ..................................................................................................................................................14
ontwikkeling .............................................................................................................................................14
, Toediening en dosis ..................................................................................................................................15
Principes ..................................................................................................................................................15
Nevenwerkingen .......................................................................................................................................15
chemotherapie geïnduceerde nausea en braken (CINV) ..........................................................................15
Myelotoxiciteit (beenmergtoxiciteit) .......................................................................................................16
diarree ..................................................................................................................................................16
constipatie ...........................................................................................................................................16
orale mucositis .....................................................................................................................................16
Andere orgaantoxiciteit .........................................................................................................................16
andere ..................................................................................................................................................17
heelkunde ...................................................................................................................................17
profylactische (preventieve) heelkunde ......................................................................................................17
diagnose en staging ..................................................................................................................................17
met curatief opzet .....................................................................................................................................17
Met palliatieve opzet .................................................................................................................................17
andere procedures....................................................................................................................................18
Radiotherapie ..............................................................................................................................18
Soorten behandeling .................................................................................................................................18
toediening ................................................................................................................................................18
nevenwerkingen ........................................................................................................................................19
H2: HEMATOLOGIE ...................................................................................................................... 20
BLOED .............................................................................................................................................. 20
structuur .....................................................................................................................................20
Plasma .....................................................................................................................................................20
Definities.....................................................................................................................................20
bloedcellen .................................................................................................................................21
rode bloedcellen (RBC) .............................................................................................................................21
witte bloedcellen (WBC) ............................................................................................................................21
Bloedplaatjes (BP).....................................................................................................................................22
afwijkingen ..................................................................................................................................22
Te weinig bloedcellen ................................................................................................................................22
Anemie .................................................................................................................................................22
leucopenie............................................................................................................................................23
thrombocytopenie ................................................................................................................................23
Te veel bloedcellen ...................................................................................................................................23
polycythemie ........................................................................................................................................23
leucocytose ..........................................................................................................................................23
thrombocytose .....................................................................................................................................24
Ziektebeelden ...........................................................................................................................................24
acute leukemie .....................................................................................................................................24
lymfoom ...............................................................................................................................................24
systeemziekten .....................................................................................................................................25
lupus ................................................................................................................................................25
systeemsclerose ...............................................................................................................................25
IMMUUNSYSTEEM ................................................................................................................................ 25
Lymfoïde organen ........................................................................................................................26
primaire/centrale ......................................................................................................................................26
Beenmerg .............................................................................................................................................26
thymus (zwezerik) .................................................................................................................................26
Secundaire/perifere ..................................................................................................................................26
tonsillen en Mucosa-associated lymphoid tissue (MAlt) ..........................................................................26
lymfeklier..............................................................................................................................................26
Milt .......................................................................................................................................................26
, Overzicht ..................................................................................................................................................27
Cellen .........................................................................................................................................27
Aspecifiek = Natuurlijke of aangeboren immuniteit .....................................................................................27
Specifieke = Verworven of adaptieve immuniteit .........................................................................................27
T-lymfocyten .........................................................................................................................................28
B-lymfocyten ........................................................................................................................................28
structuur van antistoffen ...................................................................................................................29
H3: CARDIOLOGIE ....................................................................................................................... 29
BLOEDSOMLOOP ................................................................................................................................. 30
BEVLOEIING ....................................................................................................................................... 30
HOLTES ............................................................................................................................................ 30
KLEPPEN .......................................................................................................................................... 31
WAND.............................................................................................................................................. 31
WERKING.......................................................................................................................................... 31
hartcyclus ...................................................................................................................................32
prikkelgeleiding ...........................................................................................................................32
elektrocardiogram (EKG) ...........................................................................................................................32
SYMPTOMEN ...................................................................................................................................... 33
ONDERZOEKEN ................................................................................................................................... 33
ZIEKTEN ............................................................................................................................................ 34
acuut myocardinfarct ..................................................................................................................34
toepassing: acuut coronair syndroom ........................................................................................................34
Hartfalen .....................................................................................................................................35
hartritmestoornissen ...................................................................................................................35
toepassingen ............................................................................................................................................35
ziekte van de hartkleppen.............................................................................................................36
endocarditis .............................................................................................................................................37
pericarditis ..................................................................................................................................37
Tamponnade ...............................................................................................................................37
aneurysma van de abdominale aorta ............................................................................................37
perifere arteriële insufficiëntie ......................................................................................................38
Cerebrovasculair accident (CVA) ..................................................................................................38
arteriële hypertensie ....................................................................................................................38
diepe veneuze thrombose ............................................................................................................39
longembool .................................................................................................................................39
H4: NEFROLOGIE ......................................................................................................................... 40
ANATOMIE ......................................................................................................................................... 41
onderdelen van het urinair stelsel .................................................................................................41
locatie nieren ..............................................................................................................................41
bouw van de nier .........................................................................................................................41
Bloedtoevoer naar de nieren ........................................................................................................41
Het nefron ...................................................................................................................................42
Glomerulus (vasculair) ..............................................................................................................................42
Tubulus (epitheliaal) .................................................................................................................................42
Werking van ADH op DTC en verzamelbuis .................................................................................................43
fysiologische processen ............................................................................................................................43
Bijnier .........................................................................................................................................43
Werking nieren ............................................................................................................................44
FUNCTIES NIEREN ............................................................................................................................... 45
,ONDERZOEKEN ................................................................................................................................... 45
urineonderzoek ...........................................................................................................................45
bloedonderzoek ..........................................................................................................................46
beeldvorming ..............................................................................................................................46
Andere onderzoeken ....................................................................................................................46
AANDOENINGEN ................................................................................................................................. 46
acute nierinsufficiëntie ................................................................................................................46
chronische nierinsufficiëntie ........................................................................................................47
nefrotisch syndroom ....................................................................................................................47
nierstenen ...................................................................................................................................48
pyelonefritis ................................................................................................................................48
, H1: KANKER
ALGEMEEN
DEFINITIE EN KENMERKEN
• Gekarakteriseerd door ongecontroleerde celdeling à groei van abnormaal weefsel
• Normaal vs kanker
Normaal Kanker
o Ontwikkeling en groei o Groei zonder de wetten van
o Volwassen weefsels het ecosysteem te
§ Homeostase behouden respecteren
– Stabiele toestand o Onaangepaste groei
– Herstel § Niet-adaptief:
§ Adaptief inspelen op wijzigende situaties zonder uitlokkende
– Hyperplasie = meer cellen aanmaken fysiologische
– Hypertrofie = grotere cellen aanmaken stimulus
– Flexibel en reversiebel § Niet flexibel of
reversibel: zonder
spontaan uitdoven
• Benigne vs maligne tumor
Benigne = goedaardig Maligne = kwaadaardig
Begrenzing Scherp Onregelmatig
Kapsel Frequent Zelden
Groeiwijze Niet-invasief Invasief
Groeisnelheid Laag Hoog
Necrose Zelden Frequent
Differentiatie Goed Slecht
Mitotische activiteit Laag Hoog
Metastasering Niet Wel
• Deling
1
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
√ Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, Bancontact of creditcard voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper friekemestdagh. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor €10,49. Je zit daarna nergens aan vast.
Is Stuvia te vertrouwen?
4,6 sterren op Google & Trustpilot (+1000 reviews)
Afgelopen 30 dagen zijn er 80364 samenvattingen verkocht
Opgericht in 2010, al 14 jaar dé plek om samenvattingen te kopen